Source:Vaccine, Volume 35, Issue 42
Author(s): Marcelle Moura Silveira, Thaís Larré Oliveira, Rodrigo Andrade Schuch, Alan John Alexander McBride, Odir Antônio Dellagostin, Daiane Drawanz Hartwig
Leptospirosis is an infectious disease caused by pathogenic Leptospira species. The vaccines that are currently available for leptospirosis are composed of whole-cell preparations and suffer from limitations such as low efficacy, multiple side-effects, poor immunological memory and lack of cross-protection against different serovars of Leptospira spp. In light of the global prevalence of this disease, the development of a more effective vaccine against leptospirosis is of paramount importance. Genetic immunization is a promising alternative to conventional vaccine development. In the last 25years, several novel strategies have been developed for increasing the efficacy of DNA vaccines. Examples of such strategies include the introduction of novel plasmid vectors, adjuvants, alternate delivery routes, and prime-boost regimens. Herein we discuss the latest and most promising advances that have been made in developing DNA vaccines against leptospirosis. We also deliberate over the future directions that must be undertaken in order to improve results in this field.
http://ift.tt/2xyP30t
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου